Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults.

Eelko Hak, Diederick E. Grobbee, E. A. M. Sanders, +10

PubMed

Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine Compared to Those of a 7-Valent Pneumococcal Conjugate Vaccine Given as a Three-Dose Series with Routine Vaccines in Healthy Infants and Toddlers

Susanna Esposito, S. Tansey, Allison Thompson, +12

Clinical and Vaccine Immunology

Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age

Matthew D. Snape, Chaam L. Klinger, Elvis D. Daniels, +17

The Pediatric Infectious Disease Journal

Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model

Akke Vellinga, S. Tansey, Belinda Hanahoe, +3

Journal of Antimicrobial Chemotherapy

Echocardiographic screening in neonates undergoing surgery for selected gastrointestinal malformations.

Robert Tulloh, S. Tansey, Karan Parashar, +3

Archives of Disease in Childhood Fetal & Neonatal

NeonatologyPediatric Heart DiseaseGastroenterologyDiagnosisSurgery +15

Tracheoesophageal speech: Predictors of success and social validity ratings

Evangeline Cantu, William J. Ryan, S. Tansey, +1

American Journal of Otolaryngology

Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Vaccines in India

Y. K. Amdekar, Sanjay Lalwani, Ashish Bavdekar, +11

The Pediatric Infectious Disease Journal

Standardizing Safety Assessment and Reporting for Neonatal Clinical Trials

Jonathan M. Davis, Gerri Baer, Susan McCune, +16

The Journal of Pediatrics

Neonatal ResuscitationNeonatologyPatient SafetyPediatricsOutcomes Research +2

Phase 3 trial evaluating the immunogenicity, safety, and tolerability of manufacturing scale 13-valent pneumococcal conjugate vaccine

Janusz Gadzinowski, Piotr Albrecht, Barbara Hasiec, +10

Vaccine

VaccinationVaccine SafetyVaccine DevelopmentImmunologyInfection Control +4

Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date

Z. Alfirevic, Kees Boer, Paul Brocklehurst, +4

BJOG An International Journal of Obstetrics & Gynaecology